Enhanced BDNF serum levels in patients with severe pathological gambling

Addiction Biology

Volumn 18, Issue 4, 2013, Pages 749-751

  Angelucci, Francesco ^a   Martinotti, Giovanni ^b   Gelfo, Francesca ^a   Righino, Elisabetta ^b   Conte, Gianluigi ^b   Caltagirone, Carlo ^a   Bria, Pietro ^b   Ricci, Valerio ^a,b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

BDNF; dopamine; ELISA; pathological gambling; serum levels; SOGS

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ANALYSIS OF VARIANCE; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; DOPAMINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GAMBLING; HUMANS; REWARD; SEVERITY OF ILLNESS INDEX; VIDEO GAMES;

EID: 84879463143     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2011.00411.x     Document Type: Article

References (12)

1. Angelucci F, Ricci V, Martinotti G, Palladino I, Spalletta G, Caltagirone C, Bria P, (2010) Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms. Addict Biol 15: 365-367.
2. Connor B, Dragunow M, (1998) The role of neuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev 27: 1-39. (Pubitemid 28300281)
3. Hewig J, Kretschmer N, Trippe RH, Hecht H, Coles MG, Holroyd CB, Miltner WH, (2010) Hypersensitivity to reward in problem gamblers. Biol Psychiatry 67: 781-783.
4. Linnet J, Møller A, Peterson E, Gjedde A, Doudet D, (2011) Dopamine release in ventral striatum during Iowa Gambling Task performance is associated with increased excitement levels in pathological gambling. Addiction 106: 383-390.
5. Lorains FK, Cowlishaw S, Thomas SA, (2011) Prevalence of comorbid disorders in problem and pathological gambling: systematic review and meta-analysis of population surveys. Addiction 106: 490-498.
6. Reuter J, Raedler T, Rose M, Hand I, Glascher J, Buchel C, (2005) Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 8: 147-148. (Pubitemid 40194043)
7. Ricci V, Martinotti G, Gelfo F, Tonioni F, Caltagirone C, Bria P, Angelucci F, (2011) Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. Psychopharmacology 215: 143-148.
8. Scalzo P, Kümmer A, Bretas TL, Cardoso F, Teixeira AL, (2010) Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease. J Neurol 257: 540-545.
9. Tremblay AM, Desmond RC, Poulos CX, Zack M, (2011) Haloperidol modifies instrumental aspects of slot machine gambling in pathological gamblers and healthy controls. Addict Biol 16: 467-484.
10. Voon V, Thomsen T, Miyasaki JM, de Souza M, Shafro A, Fox SH, Duff-Canning S, Lang AE, Zurowski M, (2007) Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 64: 212-216.
11. Zack M, Poulos CX, (2004) Amphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers. Neuropsychopharmacology 29: 195-207. (Pubitemid 38068030)
12. Zack M, Poulos CX, (2007) A D2 antagonist enhances the rewarding and priming effects ofa gambling episode in pathological gamblers. Neuropsychopharmacology 32: 1678-1686. (Pubitemid 47076378)